GWSA
PFE icon

Global Wealth Strategies & Associates’s Pfizer PFE Stock Holding History

Global Wealth Strategies & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,171
Closed -$61K – 344
2026
Q1 		$61K Buy
2,171
+404
+23% +$10.8K 0.02% 154
2025
Q4 		$44K Buy
1,767
+1,011
+134% +$25.5K 0.01% 165
2025
Q3 		$19.3K Buy
756
+11
+1% +$272 0.01% 225
2025
Q2 		$18.1K Sell
745
-115
-13% -$2.68K 0.01% 172
2025
Q1 		$21.8K Buy
860
+590
+219% +$15.4K 0.01% 178
2024
Q4 		$7.17K Buy
270
+15
+6% +$407 ﹤0.01% 244
2024
Q3 		$7.38K Sell
255
-2,770
-92% -$80.8K ﹤0.01% 210
2024
Q2 		$84.6K Buy
3,025
+193
+7% +$5.31K 0.03% 65
2024
Q1 		$78.6K Sell
2,832
-1
-0% -$28 0.03% 66
2023
Q4 		$81.5K Sell
2,833
-41
-1% -$1.24K 0.03% 64
2023
Q3 		$95.3K Buy
2,874
+42
+1% +$1.49K 0.04% 58
2023
Q2 		$104K Sell
2,832
-24
-0.8% -$934 0.05% 56
2023
Q1 		$117K Hold
2,856
– – 0.06% 48
2022
Q4 		$146K Buy
+2,856
New +$137K 0.08% 44

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Global Wealth Strategies & Associates's PFE Position: Q2 2026 in Review

Global Wealth Strategies & Associates sold out of Pfizer (PFE) in Q2 2026, closing a stake of 2,171 shares — an estimated $61K sold.

Global Wealth Strategies & Associates first reported a position in PFE in Q4 2022 and held it in 14 quarters. The position peaked at $146K in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Global Wealth Strategies & Associates reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 2,171 Pfizer shares in Q2 2026, an estimated $61K.
  • Global Wealth Strategies & Associates first reported a position in Pfizer in Q4 2022 and held it in 14 quarters.
  • Global Wealth Strategies & Associates's Pfizer position peaked at $146K in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q2 2026, filed 1 Jul 2026.